A Soluble Form of Fibroblast Growth Factor Receptor 2 (FGFR2) with S252W Mutation Acts as an Efficient Inhibitor for the Enhanced Osteoblastic Differentiation Caused by FGFR2 Activation in Apert Syndrome

This publication has 58 references indexed in Scilit:

• De Novo Alu-Element Insertions in FGFR2 Identify a Distinct Pathological Basis for Apert Syndrome
  American Journal of Human Genetics, 1999
• Genotype-phenotype correlation for nucleotide substitutions in the IgII- IgIII linker of FGFR2
  Human Molecular Genetics, 1997
• Fibroblast growth factor receptor 2 mutations in Beare–Stevenson cutis gyrata syndrome
  Nature Genetics, 1996
• Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes
  Nature Genetics, 1995
• Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome
  Nature Genetics, 1995
• Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2
  Nature Genetics, 1994
• A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome
  Nature Genetics, 1994
• Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome
  Nature Genetics, 1994
• New indirect method for estimating the birth prevalence of the Apert syndrome
  International Journal of Oral & Maxillofacial Surgery, 1992
• Birth prevalence study of the apert syndrome
  American Journal of Medical Genetics, 1992